This trial is testing a new treatment for men with metastatic prostate cancer that hasn't responded to other treatments. The new treatment is a combination of two drugs, one of which is testosterone.
- Prostate Adenocarcinoma
- Prostate Cancer
- Castration-resistant Prostate Cancer
1 Primary · 10 Secondary · Reporting Duration: 24 months
1 Treatment Group
Bipolar Androgen Therapy in addition to RADium-223 (RAD)
1 of 1
47 Total Participants · 1 Treatment Group
Primary Treatment: radium-223 · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · Male Participants · 12 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants have been recruited for this experiment?
"Affirmative. According to the data on clinicaltrials.gov, this clinical trial is still open and actively seeking patients since it was initially posted on April 28th 2022. The study requires 47 participants from 2 distinct sites for recruitment." - Anonymous Online Contributor
Is this a pioneering clinical investigation?
"Presently, there are 7 active Bipolar Androgen Therapy (BAT) trials operating in 40 cities and 4 nations. This medical research dates back to Merck Sharp & Dohme LLC's 2017 Phase 2 trial involving 45 participants; since then 8 further studies have reached completion." - Anonymous Online Contributor
Has the FDA officially sanctioned Bipolar Androgen Therapy (BAT) for medical use?
"Since the data for Bipolar Androgen Therapy (BAT) is only up to Phase 2, there are no efficacy studies conducted yet. Thus, this treatment has been assigned a safety rating of 2 out of 3 by our team at Power." - Anonymous Online Contributor
Is this experiment currently accepting participants?
"Per the details posted on clinicaltrials.gov, this medical research is currently recruiting participants and was initially uploaded April 28th 2022 with a subsequent update the following day." - Anonymous Online Contributor
Has Bipolar Androgen Therapy been evaluated in past clinical research?
"Currently, there are seven ongoing studies assessing the efficacy of Bipolar Androgen Therapy (BAT), with one in its most advanced phase. While many trials for BAT originate from Bethesda, Maryland, 62 medical sites across the globe have opened their doors to those studying this therapy." - Anonymous Online Contributor